Even if claims against individual
health care providers were likely to be successful, it should be added that tort law challenges to individual decision - makers may not be ideal from the perspective of patients with rare diseases as a group, as the
individualized outcome in tort cases does not necessarily lead to the larger, policy change desired
by many patients.